Edge Animal Health offers biotechnology solutions that focus on a bi-directional approach to develop novel therapeutics and vaccines.
Edge Animal Health has raised $11.0M in total funding. The most recent round was Series B. The last funding was announced in June 2024.
Edge Animal Health's investors include Anterra Capital, Endeavor8.
Edge Animal Health is headquartered in New Jersey, Trinidad and Tobago.
Edge Animal Health offers biotechnology solutions that focus on a bi-directional approach to develop novel therapeutics and vaccines.
Edge Animal Health is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Edge Animal Health — Funding & Investors." VCBacked, June 17, 2024, https://www.vcbacked.co/company/edge-animal-health. Accessed August 14, 2026.
VCBacked. (2024). Edge Animal Health — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/edge-animal-health
{{cite web |title=Edge Animal Health — Funding & Investors |url=https://www.vcbacked.co/company/edge-animal-health |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated